CGT Leader Panel: How to Turn Regulatory Demands Into Innovation Drivers
Scale CGT Manufacturing—Without Compromise
Cell and gene therapy (CGT) manufacturing is entering a new era. As the industry transitions from clinical development to commercial-scale production, CGT manufacturers face mounting pressure to maintain compliance, ensure patient safety, and accelerate timelines—all while managing the complexities of batch-of-one production. Digital transformation is no longer a future consideration; it's the foundation of sustainable scale. This industry brief, drawn from a panel discussion with CGT manufacturing experts, explores how connected digital systems are reshaping the way quality, manufacturing, and asset management work together—and what your organization needs to build a scalable, audit-ready operation.
You’ll learn:
How leading CGT manufacturers are moving from paper-based records to fully digital, audit-ready systems that support regulatory compliance at scale.
Why connectivity between manufacturing execution, quality management, and asset tracking is critical to achieving consistent batch outcomes and patient safety.
What a phased approach to digital transformation looks like for CGT organizations at every stage of maturity.
Trusted By These Life Sciences Leaders
See Why Connectivity Is Integral in CGT Manufacturing
In CGT manufacturing, siloed systems create dangerous gaps. When quality records, manufacturing execution, and equipment data operate independently, critical information is delayed, traceability suffers, and compliance becomes reactive rather than proactive. The most successful CGT manufacturers are those who have built connected digital environments, where every batch step, deviation, and process parameter is automatically linked to quality records in real time. This level of connectivity isn't just an operational advantage. It's the infrastructure that enables manufacturers to scale confidently, respond quickly to issues, and demonstrate compliance to regulators when it matters most.
See what MasterControl users are saying
Are You Ready for the Digital Future of CGT?
Read the brief and get strategies that matter most to CGT scale.
MasterControl: Built for CGT Excellence
MasterControl's connected platform unifies quality, manufacturing, and asset management processes in a single environment, giving CGT manufacturers the visibility, traceability, and control needed to scale from clinical development to commercial production without ever compromising compliance or patient safety.
-
Unified Manufacturing
MasterControl's Manufacturing Excellence (Mx) solution connects digital batch records, deviation tracking, and process execution in a single environment, delivering the real-time visibility CGT manufacturers need to maintain consistent batch outcomes.
-
Connected Quality
MasterControl Quality Excellence (Qx) embeds compliance checks directly into production workflows, ensuring every deviation, change, and process parameter is captured, linked, and audit-ready, without the manual effort of traditional paper-based systems.
-
Asset Management
MasterControl's Asset Excellence (Ax) keeps calibration records, maintenance schedules, and equipment utilization data accessible in real time, ensuring your equipment never becomes the bottleneck in a patient-critical manufacturing process.
-
Scalable Compliance
With over 1,200 life sciences companies worldwide relying on MasterControl, the fully integrated platform is proven to help organizations reduce costs, accelerate time to market, and build the digital infrastructure needed for commercial CGT success.